Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
AMD Severity ScaleAstigmatism AssistantBarrett / SRK-T SimDiabetic Retinopathy RiskGlaucoma ProgressionGlaucoma Risk (OHTS)Graves CASHFA MD to VFI ConverterIOP Correction (CCT)LogMAR <-> SnellenMRD AssessmentROP Risk (G-ROP)SPEED Score (Dry Eye)SUN Uveitis GradingVertex Distance
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

AMD Severity Scale

Select the category that best describes the macular findings (per AREDS guidelines).

Guidelines & Evidence

Verified

Last Review: 2026-07-17

How it Works

AREDS Classification

Category 1: No or few small drusen (<63µm)
Category 2 (Early): Many small drusen or few intermediate drusen (63-124µm)
Category 3 (Intermediate): At least one large druse (>125µm) or extensive intermediate drusen
Category 4 (Advanced): Geographic atrophy or neovascular AMD

Clinical Pearls

AREDS Supplementation

AREDS2 antioxidants and zinc are clinically indicated for patients in Category 3 or 4 (in one eye) to reduce the 5-year risk of progression by approx 25%.

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.